MedTrace Logo

Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence

NCT04107051 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 533

Last updated 2025-03-21

No results posted yet for this study

Summary

The purpose of this study is to investigate the safety and the prognosis after achieving reduced alcohol intake in patients with alcohol dependence who received treatment for the reduction of alcohol intake in the routine clinical setting in Japan.

Conditions

  • Alcohol Dependence

Interventions

DRUG

Nalmefene Hydrochloride Hydrate

Oral administration of nalmefene hydrochloride hydrate

Sponsors & Collaborators

  • Otsuka Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yasuhiko Fukuta, PhD · Otsuka Pharmaceutical Co., Ltd.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2023-02-07
Completion
2024-02-06

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04107051 on ClinicalTrials.gov